[{"address1": "100 Overlook Center", "address2": "Suite 102", "city": "Princeton", "state": "NJ", "zip": "08540", "country": "United States", "phone": "609 375 2227", "website": "https://www.sonnetbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 to treat chemotherapy-induced peripheral neuropathy (CIPN), and diabetic peripheral neuropathy; SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer; SON-1411, a bifunctional combination of human interleukin 18 (IL-18) inhibitor binding protein and single-chain human IL-12 (IL-12) for solid tumor cancers; and SON-1400, a monofunctional fusion protein comprising the IL-18 binding protein resistant domain linked to the FHAB. It has a license agreement with New Life Therapeutics Pte, Ltd. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Mr. Raghu  Rao", "age": 61, "title": "Interim CEO & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 116500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John K. Cini Ph.D.", "age": 71, "title": "Chief Scientific Officer & Co-Founder", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 397750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen J. McAndrew Ph.D.", "age": 70, "title": "President & Chief Business Officer", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gael  Hedou Ph.D.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susan  Dexter", "age": 69, "title": "Chief Technical Officer", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard T. Kenney FACP, M.D.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Manuel  Dafonseca", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 4.7, "open": 4.87, "dayLow": 4.685, "dayHigh": 5.15, "regularMarketPreviousClose": 4.7, "regularMarketOpen": 4.87, "regularMarketDayLow": 4.685, "regularMarketDayHigh": 5.15, "payoutRatio": 0.0, "beta": 1.345, "forwardPE": -0.33556148, "volume": 518825, "regularMarketVolume": 518825, "averageVolume": 898040, "averageVolume10days": 577240, "averageDailyVolume10Day": 577240, "bid": 4.94, "ask": 5.09, "bidSize": 1, "askSize": 1, "marketCap": 34273308, "fiftyTwoWeekLow": 1.08, "fiftyTwoWeekHigh": 19.3, "allTimeHigh": 8008000.0, "allTimeLow": 1.08, "priceToSalesTrailing12Months": 34.273308, "fiftyDayAverage": 4.6218, "twoHundredDayAverage": 2.73085, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 33654388, "profitMargins": 0.0, "floatShares": 6743545, "sharesOutstanding": 6827352, "sharesShort": 2184854, "sharesShortPriorMonth": 2235520, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.32, "heldPercentInsiders": 0.04247, "heldPercentInstitutions": 0.034479998, "shortRatio": 1.99, "shortPercentOfFloat": 0.3205, "impliedSharesOutstanding": 6827352, "bookValue": -0.914, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -13556225, "trailingEps": -6.82, "forwardEps": -14.96, "lastSplitFactor": "1:8", "lastSplitDate": 1727654400, "enterpriseToRevenue": 33.654, "enterpriseToEbitda": -2.396, "52WeekChange": 0.15935338, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 5.02, "targetHighPrice": 20.0, "targetLowPrice": 20.0, "targetMeanPrice": 20.0, "targetMedianPrice": 20.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 321297, "totalCashPerShare": 0.048, "ebitda": -14047793, "totalDebt": 68837, "quickRatio": 0.18, "currentRatio": 0.259, "totalRevenue": 1000000, "revenuePerShare": 0.369, "returnOnAssets": -2.23803, "grossProfits": -767527, "freeCashflow": -6010179, "operatingCashflow": -10310714, "grossMargins": -0.76752996, "ebitdaMargins": 0.0, "operatingMargins": -14.058669, "financialCurrency": "USD", "symbol": "SONN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Sonnet BioTherapeutics Holdings", "longName": "Sonnet BioTherapeutics Holdings, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1162305000000, "postMarketChangePercent": -0.6494009, "postMarketPrice": 4.9874, "postMarketChange": -0.032599926, "regularMarketChange": 0.32, "regularMarketDayRange": "4.685 - 5.15", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 898040, "fiftyTwoWeekLowChange": 3.94, "fiftyTwoWeekLowChangePercent": 3.648148, "fiftyTwoWeekRange": "1.08 - 19.3", "fiftyTwoWeekHighChange": -14.279999, "fiftyTwoWeekHighChangePercent": -0.73989636, "fiftyTwoWeekChangePercent": 15.935337, "dividendDate": 1585785600, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.82, "epsForward": -14.96, "epsCurrentYear": -3.46, "priceEpsCurrentYear": -1.450867, "fiftyDayAverageChange": 0.39820004, "fiftyDayAverageChangePercent": 0.08615692, "twoHundredDayAverageChange": 2.28915, "twoHundredDayAverageChangePercent": 0.83825547, "priceToBook": -5.4923415, "corporateActions": [], "postMarketTime": 1761953942, "regularMarketTime": 1761940801, "exchange": "NCM", "messageBoardId": "finmb_410378138", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.80852, "regularMarketPrice": 5.02, "displayName": "Sonnet BioTherapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]